AESI Case Definition Companion Guide: Anaphylaxis Version 2

This document replaces an earlier version of the Anaphylaxis Companion Guide (completed Feb 5, 2021) which accompanied the 2007 Anaphylaxis case definition. A new Working Group was formed in 2021 to review and revise the 2007 Anaphylaxis case definition (Anaphylaxis V-1) due to identified issues of the V-1 definition over-calling events with allergic symptoms as anaphylaxis. The new V-2 case definition was completed in September 2022, and this Companion Guide updates the previous one primarily as regards the tools for data abstraction and application to determine level of certainty. No changes were needed for the other sections including risk factors, background rates and ICD9/10-CM & MedDRA codes. This guide should replace the earlier version and can be used by stakeholders to assess the occurrence of anaphylaxis in several settings including as an adverse event following immunization.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-09-09
DOI
https://doi.org/10.5281/zenodo.6668844
Primary Topic
Food Allergy and Anaphylaxis Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

AESI Case Definition Companion Guide: Anaphylaxis Version 2

Zenodo (CERN European Organization for Nuclear Research)
Food Allergy and Anaphylaxis Research
article

AESI Case Definition Companion Guide: Anaphylaxis Version 2

article en

Abstract

This document replaces an earlier version of the Anaphylaxis Companion Guide (completed Feb 5, 2021) which accompanied the 2007 Anaphylaxis case definition. A new Working Group was formed in 2021 to review and revise the 2007 Anaphylaxis case definition (Anaphylaxis V-1) due to identified issues of the V-1 definition over-calling events with allergic symptoms as anaphylaxis. The new V-2 case definition was completed in September 2022, and this Companion Guide updates the previous one primarily as regards the tools for data abstraction and application to determine level of certainty. No changes were needed for the other sections including risk factors, background rates and ICD9/10-CM & MedDRA codes. This guide should replace the earlier version and can be used by stakeholders to assess the occurrence of anaphylaxis in several settings including as an adverse event following immunization.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 46%
Food Allergy and Anaphylaxis Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.